The filing provides pro forma financial results for Corvex, Inc. following its March 2026 acquisition of Corvex OpCo. These results integrate the operations of the newly acquired entity for the first half of 2026 as if the merger had occurred at the start of 2025, highlighting the company's shift away from its legacy consumer health focus toward high-performance infrastructure.

Key Highlights

  • Total acquisition consideration for Corvex OpCo was $582.0 million, with $519.3 million allocated to goodwill and $15.4 million to identifiable intangible assets.
  • The company completed the disposal of its legacy Movano connected devices and services segment on June 30, 2026, recording a $2.5 million gain on disposal in satisfaction of outstanding indebtedness.
  • Pro forma combined net loss for the six months ended June 30, 2026, was $26.3 million, driven primarily by $32.7 million in total combined operating costs and expenses.